| 12319698 |
Proteasome activity enhancing compounds |
Matthew Cullen, Cecilia M. Bastos, Benito Munoz |
2025-06-03 |
|
| 11560385 |
Proteasome activity enhancing compounds |
Matthew Cullen, Cecilia M. Bastos, Benito Munoz |
2023-01-24 |
$1,629,000 |
| 11248010 |
Compounds, compositions, and methods for modulating CFTR |
Benito Munoz, Cecilia M. Bastos |
2022-02-15 |
$264,000 |
| 11136313 |
Compounds, compositions, and methods for modulating CFTR |
Benito Munoz, Cecilia M. Bastos, David Kombo |
2021-10-05 |
$1,616,000 |
| 10899751 |
Compounds, compositions, and methods for increasing CFTR activity |
Cecilia M. Bastos, Matthew Cullen, Benito Munoz |
2021-01-26 |
$4,048,000 |
| 10662207 |
Compounds, compositions, and methods for modulating CFTR |
Benito Munoz, Cecilia M. Bastos |
2020-05-26 |
$2,487,000 |
| 10550106 |
Compounds, compositions, and methods for modulating CFTR |
Benito Munoz, Cecilia M. Bastos, David Kombo |
2020-02-04 |
$1,574,000 |
| 10118900 |
Benzimidazole derivatives useful as CB-1 inverse agonists |
Mark J. Macielag, Rui Zhang, Yue-Mei Zhang, Bin Zhu, Michael H. Parker +3 more |
2018-11-06 |
$103,036,000 |
| 9718820 |
Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators |
Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, William J. Parsons +2 more |
2017-08-01 |
$87,962,000 |
| 9409915 |
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, William J. Parsons +2 more |
2016-08-09 |
$153,043,000 |
| 9249163 |
PDE10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2016-02-02 |
$67,544,000 |
| 9193736 |
PDE 10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2015-11-24 |
$122,826,000 |
| 9023846 |
Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, William J. Parsons +2 more |
2015-05-05 |
$77,894,000 |
| 8680098 |
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, William J. Parsons +2 more |
2014-03-25 |
$79,525,000 |
| 8232409 |
Heterocyclic benzimidazoles as TRPM8 modulators |
Mark R. Player, William H. Parsons, Sanath K. Meegalla, Carl R. Illig, Shelley K. Ballentine |
2012-07-31 |
$66,960,000 |
| 7612211 |
Benzimidazole TRPV1 inhibitors |
Wing S. Cheung, William H. Parsons, Sharmila Patel, Mark R. Player |
2009-11-03 |
$124,164,000 |
| 7446210 |
Factor Xa compounds |
Tianbao Lu, Tho V. Thieu, Yu-Kai Lee, Thomas P. Markotan, Wenxi Pan +2 more |
2008-11-04 |
$139,488,000 |
| 7115598 |
Substituted 1,4-diazepines and uses thereof |
Tianbao Lu, Karen L. Milkiewicz, Pierre Jean-Marie Bernard Raboisson, Maxwell D. Cummings, Raul Calvo +4 more |
2006-10-03 |
$6,664,000 |
| 7067512 |
Substituted 1,4-benzodiazepines and uses thereof |
Tianbao Lu, Louis Lafrance, Karen L. Milkiewicz, Raul Calvo, Maxwell D. Cummings +3 more |
2006-06-27 |
|
